Cargando…

Drug Repositioning for Diabetes Based on 'Omics' Data Mining

Drug repositioning has shorter developmental time, lower cost and less safety risk than traditional drug development process. The current study aims to repurpose marketed drugs and clinical candidates for new indications in diabetes treatment by mining clinical ‘omics’ data. We analyzed data from ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ming, Luo, Heng, Xi, Zhengrui, Rogaeva, Ekaterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422696/
https://www.ncbi.nlm.nih.gov/pubmed/25946000
http://dx.doi.org/10.1371/journal.pone.0126082